Transcend Capital Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,000
| Closed | -$306K | – | 514 |
|
|
2023
Q2 | $306K | Hold |
3,000
| – | – | 0.03% | 366 |
|
|
2023
Q1 | $273K | Buy |
+3,000
| New | +$273K | 0.03% | 380 |
|
|
2021
Q4 | – | Sell |
-5,000
| Closed | -$485K | – | 523 |
|
|
2021
Q3 | $485K | Buy |
+5,000
| New | +$485K | 0.04% | 305 |
|
|
2021
Q2 | – | Sell |
-5,650
| Closed | -$564K | – | 453 |
|
|
2021
Q1 | $564K | Buy |
5,650
+250
| +5% | +$25K | 0.07% | 233 |
|
|
2020
Q4 | $668K | Buy |
+5,400
| New | +$668K | 0.09% | 205 |
|